GC Biopharma ensures
transparency by providing
up-to-date information to shareholders.
Stock Price Overview
GC Biopharma 006280
Opening Price (KRW)
High Price (KRW)
Low Price (KRW)
Trading Volume (Shares)
Key Financial Data
(Unit: Billions of KRW)
Presentations
Stock Information
Current Price |
Opening Price |
||
|---|---|---|---|
vs. Previous Day |
High |
||
Change |
Low |
||
Trading Volume |
Upper Limit |
||
Trading Value |
Lower Limit |
||
Previous Day |
Base Price |
||
Market Cap |
Block Trading |
0 |
|
Foreign |
Foreign |
||
PER |
0.00 |
EPS |
0 |
PBR |
0.00 |
PCR |
0.00 |
Key Financial Data
(Unit: Billions of KRW)
Revenue
Operating Profit
Profit Before Income Taxes
Net Income
Comprehensive Income
(Unit: Millions of KRW)
Details |
2022 |
2023 |
2024 |
|---|---|---|---|
Revenue |
1,711,313 |
1,626,644 |
1,679,892 |
Operating Profit |
81,264 |
34,436 |
32,107 |
Profit Before Income Taxes |
85,728 |
-27,135 |
-41,110 |
Net Income |
69,415 |
-19,809 |
-42,637 |
Comprehensive Income |
83,596 |
-3,262 |
-50,513 |
Consolidated Statement of Financial Position
(Unit: Billions of KRW)
Total Assets
Total Liabilities
Total Equity
(Unit: Millions of KRW)
Details |
2022 |
2023 |
2024 |
|---|---|---|---|
[Current Assets] |
980,438 |
1,039,149 |
1,201,834 |
[Non-Current Assets] |
1,545,099 |
1,604,165 |
1,542,042 |
Total Assets |
2,525,537 |
2,643,314 |
2,743,876 |
[Current Liabilities] |
540,738 |
868,916 |
769,475 |
[Non-Current Liabilities] |
418,157 |
234,534 |
493,385 |
Total Liabilities |
958,895 |
1,103,451 |
1,262,860 |
Total Equity |
1,566,642 |
1,539,863 |
1,481,016 |
Credit Ratings
Agency |
Credit Rating |
|---|---|
Korea Ratings |
A+ |
NICE Investors Service |
A+ |
※ Corporate bonds are subject to annual credit rating evaluations.
No.
Date
Title
Attachment
Views